Found 24 matching trials
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) PHASE4 This is an efficacy and safety study to compare aprepitant with ondansetron...
Show More Location
Multiple Locations
Learn More & Join Trial
Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting PHASE3 The goal of this clinical trial is to learn if medroxyprogesterone acetate ...
Show More Location
The First Affiliated Hospital of Xinxiang Medical University
Learn More & Join Trial
Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients PHASE2 Prevention of infectious diseases through immunization is one of the greate...
Show More Location
Radboud University Medical Center
Learn More & Join Trial
A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation PHASE3 The purpose of this study was to determine the clinical benefit of ASP2215 ...
Show More Learn More & Join Trial
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) NA The purpose of this study is to evaluate the addition of Sirolimus (rapamyc...
Show More Location
University of Pennsylvania
Learn More & Join Trial
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia. PHASE3 This is a multicenter, randomized, open-label, pragmatic low intervention c...
Show More Location
University Hospital Brno
Learn More & Join Trial
CAV Regimen for R/R AML PHASE2 This study aims to investigate the efficacy and safety of cladribine, combi...
Show More Location
The First Affliated Hospital of Soochow University
Learn More & Join Trial
Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting PHASE2 Chemotherapy-induced nausea and vomiting (CINV) adversely affects patients'...
Show More Location
The University of Alabama at Birmingham
Learn More & Join Trial
Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies PHASE2 The goal of this open, single-arm practical, phase II, clinical study is to...
Show More Status
Active Not Recruiting
Location
Union Hospital, Huazhong University of Science and Technology
Learn More & Join Trial
Sirolimus in Combination With MEC in High Risk Myeloid Leukemias PHASE1 The purpose of this study is to evaluate the side effects of sirolimus (rap...
Show More Location
University of Pennsylvania Abramson Cancer Center
Learn More & Join Trial